Novel solutions to regenerate mobility

Orthocell is developing world-leading regenerative medicine products to unlock the power of the human body to heal – restoring mobility, function and performance. It is listed on the Australian Stock Exchange (ASX:OCC) and produces Remplir™ collagen nerve wraps, Striate+™ collagen membranes, and SmrtGraft™, using the SMRT™ manufacturing process

Life-Changing Products

Life-Changing Products

Our products are purpose-built to unlock and support the body’s own repair mechanisms.

Products
Practitioners

Practitioners

We partner with key opinion-leading health care professionals to offer new therapies for complex injuries.

Practitioners
Bright Minds

Bright Minds

Our expert team develops, manufactures and commercializes regenerative medicine therapies.

Team
Investors

Investors

Orthocell is an ASX-listed company, with a solid performance history and high growth potential.

Invest
A Compelling Investment Opportunity
"Nature originally inspired the development of Orthocell’s products. I was fascinated by the loosely arranged bundles that make up the structure of a sea sponge – so I developed a collagen medical device that mimicked these interconnected particles."

Co-Founder and Chief Scientific Officer, Professor Ming Hao Zheng

FDA Clearance for Remplir™

Orthocell is redefining nerve repair with Remplir™ – now FDA cleared.

Learn more
"Orthocell is a leading example of the capacity for Australian biotechnology companies to translate world-class research into commercially viable and life-changing products – manufactured on home soil."

Co-Founder and Managing Director, Paul Anderson